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1. Introduction 
Daunomycin inhibits nucleic acid synthesis both 
in a cell-free system [ 1, 21 and in vivo [3, 41. This 
antitumour antibiotic of the anthracycline group 
binds very strongly to DNA. A considerable body 
of evidence has been accumulated which points to 
an intercalative mode of binding [ 1, s-71. 
Lerman [8] has established that an increase in 
intrinsic viscosity and a decrease in the sedimenta- 
tion coefficient are two hydrodynamic criteria for 
intercalation of ring systems between base pairs of 
double-helical DNA. In a systematic investigation 
of drugs believed to intercalate, Waring [9] report- 
ed that changes in supercoiling of closed circular 
DNA may be employed to verify intercalative bind- 
ing. This variation of supercoils, a result of drug- 
induced local uncoiling of the double helix, are 
revealed by changes in the sedimentation coefficient. 
Recently [lo] , a viscosimetric method has been de- 
veloped for following the configurational changes 
in closed circular DNA. The theoretical and prac- 
tical aspects of these phenomena are consistent with 
the model of Lerman [8]. 
In this paper we present the results of the be- 
haviour of daunomycin on DNA-cellulose column 
chromatography and of low-shear viscosimetry. These 
two experimental methods were complementary in 
that the former provides information regarding the 
occurrence of different types of interaction, while 
the latter yields indication of the size and shape of 
the daunomycin-DNA complex. This dual approach 
has improved our understanding of the interaction. 
2. Materials and methods 
Daunomycin hydrochloride (M.W. 563.5) was 
supplied by Farmitalia, Milano. The antibiotic was 
stored in the dark in a dessicator at 4”. Solutions 
in buffer were freshly prepared immediately before 
use. 
Calf thymus DNA was isolated according to the 
procedure of Zamenhof [ 1 l] . Denaturation was 
accomplished by heating at 90” for 10 min in 0.001 
M NaCl, followed by fast cooling. Sonicated DNA 
was prepared as reported by Doty et al. [ 121. 
Spectrophotometric measurements were carried 
out in a Zeiss PMQII or a Beckman DU spectro- 
photometer. 
The DNA-cellulose column chromatography was 
carried out as described by Inagaki and Kageyama 
[ 131. Methods particular to this study will be de- 
scribed in the following. 
Viscosities were measured at 20” by means of a 
Zimm-Crother low shear viscosimeter adjusted to 
give a shear stress of less than 0.002 dynes/cm’. 
3. Results and discussion 
Fig. 1 shows the elution pattern of daunomycin 
on DNA-cellulose. When 0.2 ml of 0.5% solution 
was applied to the column, using the stepwise elu- 
tion technique (fig. l), about 75% of the drug was 
eluted by 2 M NaCl and the rest was dissociated by 
addition of 7 M urea to 2 M NaCl. 
Using the gradient elution procedure, the chroma- 
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Fig. 1. DNA-cellulose chromatography of daunomycin. 0.2 
ml of 0.5% daunomycin solution (in 0.01 M Tris, 0.001 M 
EDTA, pH 7.0) were loaded on a 0.6 X 4 cm column. The 
daunomycin loading took place at fraction 0. After loading, 
the column was washed with the buffer and the bound ma- 
terial was eluted by 2 M NaCl and successively by 7 M urea 
in 2 M NaCl-0.01 M Tris-0.001 M EDTA, pH 7.0. The 
stepwise elutions are indicated by the vertical arrows. Frac- 
tions of 3.7 ml were collected. Recovery was 100%. Flow 
rate, 37 ml/hr. 
tographic pattern shows two peaks centered at about 
0.2-0.4 M in NaCl gradient and at about 2.5-3 M 
in urea gradient. This finding parallels the results 
obtained with the stepwise elution technique (fig. 1). 
When daunomycin samples were loaded at two dif- 
fering concentrations (table l), the amount of 
daunomycin dissociated by urea gradient is not 
markedly affected by increasing the amount of the 
sample loaded. The purity of daunomycin sample 
used was checked by thin layer chromatography. It 
is unlikely that the chromatographic behaviour can 
be attributed to a mixture of two different mole- 
cular species. In addition, the amount of drug re- 
tained by cellulose alone is negligible (table 1). 
These experiments agree with the spectrophoto- 
metric titration of daunomycin with DNA [ 141 . The 
adsorption isotherm (“Scatchard plot”) indicates 
the existence of more than one class of binding sites 
for daunomycin on DNA. This conclusion is clearly 
Table 1 
Comparison of the amount of daunomycin dissociated by 
7 M urea in 2 M NaCl from a DNA-cellulose column. 
Amount eluted r (molar 
by urea grad- ratio an- 
Load ient tibiotic/ 
(mg) (mg) DNA I’) 
Control** negligible 
(cellulose alone) 1.140 (0.005) _ 
DNA-cellulose* 1.140 0.162 0.125 
DNA-cellulose* 5.560 0.202 0.156 
Conditions are as illustrated in legend to fig. 1. 
* Elution was carried out with a linear molarity gradient 
(SO + 50 ml) of NaCl (O-2 M) and successively with a 
linear molarity gradient (100 + 100 ml) of urea (O-7 M) 
in 2 M NaCl. 
** In this experiment, acid-washed cellulose was used. After 
loading, the column was washed with the buffer. Elution 
was carried out stepwise, according to the scheme shown 
in fig. 1. 
supported by the chromatographic behaviour of 
daunomycin on DNA-cellulose column. 
The present results suggest a weak binding mode 
of interaction, probably electrostatic, between anti- 
biotic molecules and DNA, involving the DNA phos- 
phate groups and daunomycin amino group; and a 
stronger binding mode requiring urea for the disso- 
ciation. 
To understand the strong binding of daunomycin 
to DNA it has been suggested that drug molecules 
intercalate between successive base pairs of the 
double helix, a process accomodated by a lengthen- 
ing and a slight local untwisting of the helix. 
This possibility is supported by the marked effects 
of the binding of daunomycin to DNA on its con- 
formation. Many features of the interaction between 
daunomycin and DNA [S, 7, IS] are similar to 
those reported for acridine dyes and similar planar 
compounds, which were postulated by Lerman [8] 
to intercalate between base pairs in the DNA com- 
plex. Daunomycin-induced increase in viscosity and 
decrease in sedimentation of native DNA are consis- 
tent with the intercalation hypothesis. Other authors 
reported an increase in the relative viscosity [S, 151 
and reduced specific viscosity [7] of native DNA of 
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Fig. 2. Determination of intrinsic viscosity of RNA-daunomycin complexes for different values of “r” with sonicated (native) DNA. 
Conditions of the viscosity measurements; 2@, 0.1 M Tris, pH 7.0. Concentrations (C) of DNA are given in molarities of DNA 
phosphorus. 
high molecular weight. Although a provisional inter- 
pretation of this increase was attempted, it could 
not be securely based, because the points on the 
plot of the relative (or reduced} viscosity as a func- 
tion of drug concentration correspond to DNA 
attached to different amounts (r) of antibiotic. 
Therefore, a refinement of the viscosity measure- 
ments was performed in order to obtain the rela- 
tion between the intrinsic viscosity of DNA and the 
amount (r) of antibiotic bound to it, 
Fig. 2 shows the curves used to determine intrin- 
sic viscosities. Dilutions were carried out at constant 
“r” by adding solvent containing aconcentration 
(m) of free daunomycin according to the method 
of Mtiller and Crother 1163 . The relationships 
between the intrinsic viscosity of sonicated native 
DNA and the amount @) of bound daunomycin 
are presented in fig. 3. In this figure the intrinsic 
viscosity of each drug-DNA complex has been di- 
vided by the intrinsic viscosity of DNA alone. 
The effects on viscosity shown are qualitatively 
consistent with previous reports 15, 7, 151. The in- 
trinsic viscasities of the complexes increase with 
‘7’ up to “r” values (about 0.16-0.20) correspond- 
ing closely both to the apparent number of binding 
sites per nucleotide (r = 0.12), obtained by extrapola- 
tion of the curve for small values of “r”, in the 
spectrophotometric t tration of daunomycin with 
DNA 1141 and to the molar ratio drug/nucleotides 
(about 0.12-0.16) recovered by ureagradient, in
DNA cellulose column (table 1). 
It has been reported [171 that the changes in 
hydrodynamic properties of sonicated DNA frag- 
ments, arising from the intercalation of dye mole- 
cules, should be almost exclusively due to an in- 
crease in contour length with respect o viscosity. 
The present results with sonicated DNA could be 
tentatively explained by a similar mechanism as pro- 
posed for a&dine dyes. Relevant o this point is 
the observation that the viscosity increase reported 
for aminoacridines [ 18, 193 is very similar to those 
presented here. In the case of acridine dyes, the 
change in viscosity, up to an ‘Y’ value of about 0.2, 
corresponds closely to an increase in contour length; 
for each bound molecule roughly equal to normal 
spacing (3.35 A) between DNA base pairs. Accord- 
ing to the hypothetical model [8], intercalation of 
“r” antibiotic molecules would increase the contour 
length (L) by a factor of (1 f 2 r). This considera- 
tion suggests a comparison of f,/te (the ratio of 
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Fig. 3. Intrinsic viscosity of daunomycin-DNA complexes 
relative to intrinsic viscosity of DNA alone. 
length of the complex to that of DNA) as a func- 
tion of “r”, with the theoretical curve (1 t 2 r). 
The relative length increase (L/L,) could be 
roughly estimated by the intrinsic viscosity data, 
by using an equation applicable to rod-like mole- 
cules [I71 L/LO = Eb~lf(Pdl hlof~N1~3, where 
“p” is the axial ratio of the particle. The experi- 
mental slope of the increase of L/Lo with r (about 
1 t 2.54 r) falls rather close to that to be expected 
(1 t 2 r), if the length increased by exactly one 
base-pair spacing when one daunomycin molecule 
is bound. As this estimation is not exact, alterna- 
tively one could compare the viscosity results with 
those to be expected for pure DNA of correspond- 
ing contour length. The relative increase in viscosi- 
ty ([Q] / [q] e) has been calculated for pure DNA 
with corresponding contour length by using the 
method described by Ullman [20] for a wormlike 
chain model. The experimental viscosity enhance- 
ment for daunomycin-DNA complexes is signifi- 
cantly larger than that to be expected according 
to Ullman’s method [we used d (diameter) = 25 A, 
Q! (hydrodynamic parameter) = 10 and h (degree 
of extension) = 9.27 X 10T4]. 
This consideration suggests that the calculated 
length increase, larger than one base-pair spacing, 
could not be of marginal significance. Recent results 
with daunomycin derivatives [ 141 indicate that, 
under identical conditions of “r” and ionic strength, 
the intrinsic viscosity is enhanced less by some dauno- 
mycin derivatives than by daunomycin. The high 
daunomycin-induced viscosity increase is not com- 
pletely explained by an increase in contour length of 
the DNA chain.Other effects, such as decrease in 
flexibility of the DNA, are possible. 
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